g’day levendful
agree, it’s time to end the negativity. What’s current management good at? They’ve done extraordinarily well in picking up great assets like the tin, and our WA tenements. From what I read here, our MD is a very good geo. So maybe revisit my original idea: spin the tin into a new IPO with its own focused management and then current management can get in with what they do well; finding high quality assets. They could get drilling on our WA tenements with the cash we have now and hopefully find some new ones. Meanwhile the newco has raised enough cash in its IPO to get the cut down version up and running and away we go. Dilution would only be the amount of cash raised in the IPO. A full in specie distribution.
an IPO with the worlds largest undeveloped tin deposit, with experienced management in moving from resource to production, would get up easily imho.
then everyone’s happy.
cheers,
ned.
- Forums
- ASX - By Stock
- CRI
- Time For A New BOD
CRI
critica limited
Add to My Watchlist
3.13%
!
1.6¢

Time For A New BOD, page-50
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
-0.001(3.13%) |
Mkt cap ! $41.81M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.5¢ | $11.47K | 724.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2496616 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 3500330 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 2036616 | 0.015 |
25 | 10623313 | 0.014 |
6 | 1297002 | 0.013 |
5 | 2225543 | 0.012 |
8 | 3813725 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 3000330 | 6 |
0.017 | 787000 | 4 |
0.018 | 2823812 | 7 |
0.019 | 2378087 | 7 |
0.020 | 5788393 | 10 |
Last trade - 13.29pm 04/07/2025 (20 minute delay) ? |
Featured News
CRI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online